Abstract:Transcription activator-like effectors (TALEs), first identified in Xanthomonas bacteria, are naturally occurring or artificially designed proteins that modulate gene transcription. These proteins recognize and bind DNA sequences based on a variable numbers of tandem repeats. Each repeat is comprised of a set of ∼ 34 conserved amino acids; within this conserved domain, there are usually two amino acids that distinguish one TALE from another. Interestingly, TALEs have revealed a simple cipher for the one-to-one recognition of proteins for DNA bases. Synthetic TALEs have been used to successfully target genes in a variety of species, including humans. Depending on the type of functional domain that is fused to the TALE of interest, these proteins can have diverse biological effects. For example, after binding DNA, TALEs fused to transcriptional activation domains can function as robust transcription factors (TALE-TFs), while fused to restriction endonucleases (TALENs) can cut DNA. Targeted genome editing, in theory, is capable of modifying any endogenous gene sequence of interest; this can be performed in cells or organisms, and may be applied to clinical gene-based therapies in the future. With current technologies, highly accurate, specific, and reliable gene editing cannot be achieved. Thus, recognition and binding mechanisms governing TALE biology are currently hot research areas. In this review, we summarize the major advances in TALE technology over the past several years with a focus on the interaction between TALEs and DNA, TALE design and construction, potential applications for this technology, and unique characteristics that make TALEs superior to zinc finger endonucleases.

SunnyTALEN: A Second‐generation TALEN System for Human Genome Editing

Transcription Activator‐like Effector Nucleases (talens): A Highly Efficient and Versatile Tool for Genome Editing

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

A single-chain TALEN architecture for genome engineering.

Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease.

Molecular “Scissors” ——TALENs Mediated Site-specific Gene Modification Technology

One-Day TALEN Assembly Protocol and a Dual-Tagging System for Genome Editing

Precise Gene Modification Mediated by TALEN and Single-Stranded Oligodeoxynucleotides in Human Cells.

De Novo-Engineered Transcription Activator-Like Effector (TALE) Hybrid Nuclease with Novel DNA Binding Specificity Creates Double-Strand Breaks.

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Transcription activator‐like effector nucleases (TALENs): An efficient tool for plant genome editing

Fully Automated One-Step Synthesis of Single-Transcript TALEN Pairs Using a Biological Foundry.

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

TALE: a tale of genome editing.

Talen or Cas9-Rapid, Efficient and Specific Choices for Genome Modifications

[TALE Nuclease Engineering and Targeted Genome Modification].

ULtiMATE System for Rapid Assembly of Customized TAL Effectors

A One-Step System for Convenient and Flexible Assembly of Transcription Activator-Like Effector Nucleases (TALENs)

A TALE nuclease architecture for efficient genome editing

Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modification

Efficient and Specific Modifications of the Drosophila Genome by Means of an Easy TALEN Strategy